We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
1326
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $12.6M | 0.01% |
211,515
+62,935
| +42% | +$3.89M |
|
1327
Laureate Education
LAUR
$5.28B
| $12.6M | 0.01% |
1,268,853
+64,973
| +5% | +$629K |
|
1328
SiriusPoint
SPNT
$2.68B
| $12.6M | 0.01% |
1,675,481
+52,099
| +3% | +$393K |
|
1329
Rithm Capital
RITM
$5.69B
| $12.6M | 0.01% |
1,692,369
+295,324
| +21% | +$1.91M |
|
1330
Stride
LRN
$3.43B
| $12.6M | 0.01% |
460,807
-251,944
| -35% | -$6.06M |
|
1331
Nektar Therapeutics
NKTR
$2.58B
| $12.5M | 0.01% |
36,112
-2,486
| -6% | -$776K |
|
1332
Tapestry
TPR
$32.8B
| $12.5M | 0.01% |
943,265
+128,533
| +16% | +$1.82M |
|
1333
National Health Investors
NHI
$3.65B
| $12.5M | 0.01% |
228,025
-224,744
| -50% | -$12.3M |
|
|
CVGW
1334
DELISTED
Calavo Growers
CVGW
| $12.5M | 0.01% |
198,691
+3,699
| +2% | +$222K |
|
|
GBT
1335
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.5M | 0.01% |
197,985
-78,377
| -28% | -$5.38M |
|
|
BRSP
1336
BrightSpire Capital
BRSP
$648M
| $12.5M | 0.01% |
1,779,596
+250,887
| +16% | +$1.28M |
|
|
CALY
1337
Callaway Golf Company
CALY
$3.14B
| $12.5M | 0.01% |
711,640
-69,087
| -9% | -$960K |
|
1338
Avis
CAR
$5.02B
| $12.5M | 0.01% |
544,331
+294,209
| +118% | +$5.4M |
|
1339
Unum
UNM
$14.3B
| $12.5M | 0.01% |
750,952
-14,145
| -2% | -$223K |
|
1340
Inspire Medical Systems
INSP
$1.74B
| $12.4M | 0.01% |
142,915
+77,488
| +118% | +$5.96M |
|
1341
OFG Bancorp
OFG
$2.21B
| $12.4M | 0.01% |
930,065
-104,231
| -10% | -$1.26M |
|
1342
Opko Health
OPK
$1.02B
| $12.4M | 0.01% |
3,646,179
+284,200
| +8% | +$637K |
|
1343
Kosmos Energy
KOS
$1.48B
| $12.4M | 0.01% |
7,477,283
+2,278,442
| +44% | +$3.66M |
|
1344
Toll Brothers
TOL
$14.5B
| $12.4M | 0.01% |
380,671
-39,260
| -9% | -$1.07M |
|
1345
Flowserve
FLS
$10.2B
| $12.4M | 0.01% |
434,808
+34,917
| +9% | +$931K |
|
1346
News Corp Class A
NWSA
$15.4B
| $12.3M | 0.01% |
1,035,032
-4,299
| -0.4% | -$45.9K |
|
1347
Bankunited
BKU
$3.36B
| $12.3M | 0.01% |
605,137
+254,313
| +72% | +$4.77M |
|
1348
LivePerson
LPSN
$32.3M
| $12.2M | 0.01% |
19,711
+1,730
| +10% | +$805K |
|
1349
Acuity Brands
AYI
$10.8B
| $12.2M | 0.01% |
127,399
-2,180
| -2% | -$192K |
|
|
MAGN
1350
Magnera Corp
MAGN
$460M
| $12.2M | 0.01% |
58,425
-40
| -0.1% | -$7.59K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.